flow trial semaglutide kidney outcomes The for in T2DM halted due to interim results meeting efficacy criteria ✨ FLOW is a RCT comparing injectable semaglutide 1.0 mg with placebo as an adjunct Diabetes Distilled: Keeping kidneys FLOWing

Its a non-invasive and painless method, avoiding the discomfort of injections and making it easier to use in research

This means that restoring estrogen through HRT may actually increase your body natural GLP-1 production, amplifying the effects of exogenous GLP-1 medications

The earliest signals of food intake are processed in taste buds located on the tongue surface

In these states, beneficiaries have access to Wegovy, Zepbound and Saxenda, alongside Type 2 diabetes-indicated options such as Ozempic, Mounjaro, and Rybelsus

The use of gastric ultrasound (GUS) to help further diagnose RGC in the preoperative setting has been shown to assist providers with screening of RGC

Convenience matters, especially if many people taking GLP-1s experience side effects like nausea, which may make meal prep difficult